Critics deride WHO's ties to vaccine industry

Five of the 15 experts who sat on the WHO's emergency swine flu panel had financial ties to the drug industry, stirring fresh accusations that the group helped spur huge profits for drug companies like GlaxoSmithKline by whipping up a global frenzy over the H1N1 pandemic. WHO officials have steadfastly denied that financial considerations played any role in the pandemic declaration, which helped create a multibillion-dollar market for Big Pharma. Story

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.